Brucellosis Treatment Market, Global Outlook and Forecast 2022-2028

August 2022 | 65 pages | ID: BA807523F852EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Brucellosis Treatment in Global, including the following market information:

Global Brucellosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Brucellosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Brucellosis Treatment include Pfizer Inc., Bayer, Huvepharma, OraPharma,Inc., Merck & Co.Inc., RempexPharmaceuticals,Inc., ZeotisInc., BoehringerIngelheim International GmbH. and Elanco and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brucellosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Brucellosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Brucellosis Treatment Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injection

Global Brucellosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Brucellosis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pharmacy
• Others

Global Brucellosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Brucellosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Brucellosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Brucellosis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer Inc.
• Bayer
• Huvepharma
• OraPharma,Inc.
• Merck & Co.Inc.
• RempexPharmaceuticals,Inc.
• ZeotisInc.
• BoehringerIngelheim International GmbH.
• Elanco
• Virabc Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Brucellosis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Brucellosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRUCELLOSIS TREATMENT OVERALL MARKET SIZE

2.1 Global Brucellosis Treatment Market Size: 2021 VS 2028
2.2 Global Brucellosis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Brucellosis Treatment Players in Global Market
3.2 Top Global Brucellosis Treatment Companies Ranked by Revenue
3.3 Global Brucellosis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Brucellosis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Brucellosis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brucellosis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Brucellosis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Brucellosis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Brucellosis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injection
4.2 By Type - Global Brucellosis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Brucellosis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Brucellosis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Brucellosis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Brucellosis Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Pharmacy
  5.1.4 Others
5.2 By Application - Global Brucellosis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Brucellosis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Brucellosis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Brucellosis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Brucellosis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Brucellosis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Brucellosis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Brucellosis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Brucellosis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Brucellosis Treatment Revenue, 2017-2028
  6.3.2 US Brucellosis Treatment Market Size, 2017-2028
  6.3.3 Canada Brucellosis Treatment Market Size, 2017-2028
  6.3.4 Mexico Brucellosis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Brucellosis Treatment Revenue, 2017-2028
  6.4.2 Germany Brucellosis Treatment Market Size, 2017-2028
  6.4.3 France Brucellosis Treatment Market Size, 2017-2028
  6.4.4 U.K. Brucellosis Treatment Market Size, 2017-2028
  6.4.5 Italy Brucellosis Treatment Market Size, 2017-2028
  6.4.6 Russia Brucellosis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Brucellosis Treatment Market Size, 2017-2028
  6.4.8 Benelux Brucellosis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Brucellosis Treatment Revenue, 2017-2028
  6.5.2 China Brucellosis Treatment Market Size, 2017-2028
  6.5.3 Japan Brucellosis Treatment Market Size, 2017-2028
  6.5.4 South Korea Brucellosis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Brucellosis Treatment Market Size, 2017-2028
  6.5.6 India Brucellosis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Brucellosis Treatment Revenue, 2017-2028
  6.6.2 Brazil Brucellosis Treatment Market Size, 2017-2028
  6.6.3 Argentina Brucellosis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Brucellosis Treatment Revenue, 2017-2028
  6.7.2 Turkey Brucellosis Treatment Market Size, 2017-2028
  6.7.3 Israel Brucellosis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Brucellosis Treatment Market Size, 2017-2028
  6.7.5 UAE Brucellosis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer Inc.
  7.1.1 Pfizer Inc. Corporate Summary
  7.1.2 Pfizer Inc. Business Overview
  7.1.3 Pfizer Inc. Brucellosis Treatment Major Product Offerings
  7.1.4 Pfizer Inc. Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Inc. Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Brucellosis Treatment Major Product Offerings
  7.2.4 Bayer Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 Huvepharma
  7.3.1 Huvepharma Corporate Summary
  7.3.2 Huvepharma Business Overview
  7.3.3 Huvepharma Brucellosis Treatment Major Product Offerings
  7.3.4 Huvepharma Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Huvepharma Key News
7.4 OraPharma,Inc.
  7.4.1 OraPharma,Inc. Corporate Summary
  7.4.2 OraPharma,Inc. Business Overview
  7.4.3 OraPharma,Inc. Brucellosis Treatment Major Product Offerings
  7.4.4 OraPharma,Inc. Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.4.5 OraPharma,Inc. Key News
7.5 Merck & Co.Inc.
  7.5.1 Merck & Co.Inc. Corporate Summary
  7.5.2 Merck & Co.Inc. Business Overview
  7.5.3 Merck & Co.Inc. Brucellosis Treatment Major Product Offerings
  7.5.4 Merck & Co.Inc. Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Merck & Co.Inc. Key News
7.6 RempexPharmaceuticals,Inc.
  7.6.1 RempexPharmaceuticals,Inc. Corporate Summary
  7.6.2 RempexPharmaceuticals,Inc. Business Overview
  7.6.3 RempexPharmaceuticals,Inc. Brucellosis Treatment Major Product Offerings
  7.6.4 RempexPharmaceuticals,Inc. Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.6.5 RempexPharmaceuticals,Inc. Key News
7.7 ZeotisInc.
  7.7.1 ZeotisInc. Corporate Summary
  7.7.2 ZeotisInc. Business Overview
  7.7.3 ZeotisInc. Brucellosis Treatment Major Product Offerings
  7.7.4 ZeotisInc. Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.7.5 ZeotisInc. Key News
7.8 BoehringerIngelheim International GmbH.
  7.8.1 BoehringerIngelheim International GmbH. Corporate Summary
  7.8.2 BoehringerIngelheim International GmbH. Business Overview
  7.8.3 BoehringerIngelheim International GmbH. Brucellosis Treatment Major Product Offerings
  7.8.4 BoehringerIngelheim International GmbH. Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.8.5 BoehringerIngelheim International GmbH. Key News
7.9 Elanco
  7.9.1 Elanco Corporate Summary
  7.9.2 Elanco Business Overview
  7.9.3 Elanco Brucellosis Treatment Major Product Offerings
  7.9.4 Elanco Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.9.5 Elanco Key News
7.10 Virabc Inc.
  7.10.1 Virabc Inc. Corporate Summary
  7.10.2 Virabc Inc. Business Overview
  7.10.3 Virabc Inc. Brucellosis Treatment Major Product Offerings
  7.10.4 Virabc Inc. Brucellosis Treatment Revenue in Global Market (2017-2022)
  7.10.5 Virabc Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Brucellosis Treatment Market Opportunities & Trends in Global Market
Table 2. Brucellosis Treatment Market Drivers in Global Market
Table 3. Brucellosis Treatment Market Restraints in Global Market
Table 4. Key Players of Brucellosis Treatment in Global Market
Table 5. Top Brucellosis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Brucellosis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Brucellosis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Brucellosis Treatment Product Type
Table 9. List of Global Tier 1 Brucellosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brucellosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Brucellosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Brucellosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Brucellosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Brucellosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Brucellosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Brucellosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Brucellosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Brucellosis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Brucellosis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Brucellosis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Brucellosis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Brucellosis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Brucellosis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Brucellosis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Brucellosis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Brucellosis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Brucellosis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Brucellosis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Brucellosis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Inc. Corporate Summary
Table 31. Pfizer Inc. Brucellosis Treatment Product Offerings
Table 32. Pfizer Inc. Brucellosis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Brucellosis Treatment Product Offerings
Table 35. Bayer Brucellosis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Huvepharma Corporate Summary
Table 37. Huvepharma Brucellosis Treatment Product Offerings
Table 38. Huvepharma Brucellosis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. OraPharma,Inc. Corporate Summary
Table 40. OraPharma,Inc. Brucellosis Treatment Product Offerings
Table 41. OraPharma,Inc. Brucellosis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Merck & Co.Inc. Corporate Summary
Table 43. Merck & Co.Inc. Brucellosis Treatment Product Offerings
Table 44. Merck & Co.Inc. Brucellosis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. RempexPharmaceuticals,Inc. Corporate Summary
Table 46. RempexPharmaceuticals,Inc. Brucellosis Treatment Product Offerings
Table 47. RempexPharmaceuticals,Inc. Brucellosis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. ZeotisInc. Corporate Summary
Table 49. ZeotisInc. Brucellosis Treatment Product Offerings
Table 50. ZeotisInc. Brucellosis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. BoehringerIngelheim International GmbH. Corporate Summary
Table 52. BoehringerIngelheim International GmbH. Brucellosis Treatment Product Offerings
Table 53. BoehringerIngelheim International GmbH. Brucellosis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Elanco Corporate Summary
Table 55. Elanco Brucellosis Treatment Product Offerings
Table 56. Elanco Brucellosis Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Virabc Inc. Corporate Summary
Table 58. Virabc Inc. Brucellosis Treatment Product Offerings
Table 59. Virabc Inc. Brucellosis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Brucellosis Treatment Segment by Type in 2021
Figure 2. Brucellosis Treatment Segment by Application in 2021
Figure 3. Global Brucellosis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Brucellosis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Brucellosis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brucellosis Treatment Revenue in 2021
Figure 8. By Type - Global Brucellosis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Brucellosis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Brucellosis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Brucellosis Treatment Revenue Market Share, 2017-2028
Figure 12. US Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Brucellosis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Brucellosis Treatment Revenue Market Share, 2017-2028
Figure 24. China Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Brucellosis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Brucellosis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Brucellosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Inc. Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Huvepharma Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. OraPharma,Inc. Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck & Co.Inc. Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. RempexPharmaceuticals,Inc. Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ZeotisInc. Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BoehringerIngelheim International GmbH. Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Elanco Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Virabc Inc. Brucellosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)